Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion
Ribas Antoni, Chesney, Abernethy, Logan, Chmielowksi Bartosz, Glaspy, Lewis Karl, Huang Bo, Wang Erjian, Hsyu Poe-Hirr, Gomez-Navarro Jesus, Gerhardt Diana, Gonzalez Rene, Gordon, Marshall, Lawson
